Based on recent data, Opus Genetics, Inc. (IRD) shows an Average True Range (ATR) of 0.23 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 653.61K, indicating liquidity. These fundamental metrics provide insight into IRD's underlying financial health and market activity.
| ATR | 0.23 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 653.61K |
| Avg Vol (10 Days) | 1.38M |
Opus Genetics, Inc. (IRD) technical indicators as of February 7, 2026: the SMA 20 is 25.68%, SMA 50 at 35.12%, and SMA 200 at 92.26%. The RSI 14 value is 68.41, suggesting its current momentum. These technical analysis signals help assess IRD's price trends and potential future movements.
| SMA 20 | 25.68% |
| SMA 50 | 35.12% |
| SMA 200 | 92.26% |
| RSI 14 | 68.41 |
Opus Genetics, Inc. (IRD) stock performance overview as of February 7, 2026: The 52-week high is $3.08 (currently -1.31% below), and the 52-week low is $0.65 (currently 363.08% above). Over the past year, IRD's performance is 94.83%, compared to the S&P 500's 8.57% change.
| 52-Week High | 3.08 |
| 52-Week High Chg | -1.31% |
| 52-Week Low | 0.65 |
| 52-Week Low Chg | +363.08% |
| S&P 500 52-Week Chg | 8.57% |
According to market data, Opus Genetics, Inc. (IRD) stock's recent performance metrics show that over the last month, IRD is 11.88%, with a Year-to-Date (YTD) performance of 12.44%. Over the past year, the stock has seen a 94.83% change. These figures summarize IRD's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 |
| Low | 2.21 | 1.88 | 1.7 | 1.04 | 0.65 | 1.88 |
| Performance | +10.24% | +11.88% | +20.86% | +89.92% | +94.83% | +12.44% |
According to current financial data, IRD stock's P/E (TTM) ratio is -3.10, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for IRD, including P/S (14.11), P/B (35.43), and P/FCF (-6.28), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | IRD | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -3.1 | -1.23 | -5.15 | 32.59 |
| P/S (TTM) | 14.11 | 3.71 | 464.72 | 5.98 |
| P/B (TTM) | 35.43 | -2.38 | 9.08 | 5.47 |
| P/FCF (TTM) | -6.28 | -321.83 | -200.6 | 32.07 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep